Keppra/Levetiracetam

Keppra is manufactured by UCB, Inc. and was approved in late 1999. It is used for the treatment of seizures, migraines, autism, social anxiety and neuropathic pain. Keppra has been linked to several serious side effects, including an increase in psychotic episodes and hallucinations.

However, the side effects of the generic form of this drug, Levetiracetam, are more alarming. Levetiracetam, manufactured by Mylan Pharmaceuticals, was approved for sale in 2008. Many individuals (whose condition was well-controlled while taking Keppra) who switched to the generic form of the drug have experienced an increase in seizure activity as well an increase in the other side effects.

What is particularly alarming is that physicians are not warning patients about the risks of switching to the generic drug and pharmacists and insurance companies are encouraging or even forcing patients to use the generic form due to the difference in cost.

If you or a loved one has suffered from one of these side effects as a result of taking Keppra or have suffered from a recurrence or increase in the original condition as a result of switching to the generic form, you may be entitled to compensation. Call us at (478) 745-9002 for a free consultation.